Pharmacotherapy of adjustment disorder: A review

References

• Ansseau M, Bataille M, Briole G, De Nayer A, Fauchère PA, Ferrero F, Mertens C, Realini R, Rombaut P, Vereecken A, et al. 1996. Controlled comparison of tianeptine, alprazolam and mianserin in the treatment of adjustment disorders with anxiety and depression. Hum Psychopharmacol Clin Exp. 11:293–298.
   Web of Science ®Google Scholar
• Arbus C, Hergueta T, Duburcq A, Saleh A, Le Guern ME, Robert P, Camus V. 2014. Adjustment disorder with anxiety in old age: comparing prevalence and clinical management in primary care and mental health care. Eur Psychiatry. 29:233–238.
   PubMed Web of Science ®Google Scholar
• Arends I, Bruinvels DJ, Rebergen DS, Nieuwenhuijsen K, Madan I, Neumeyer-Gromen A, Bultmann U, Verbeek JH. 2012. Interventions to facilitate return to work in adults with adjustment disorders. Cochrane Database Syst Rev. 12:CD006389
   PubMedGoogle Scholar
• Bachem R, Perkonigg A, Stein DJ, Maercker A. 2016. Measuring the ICD-11 adjustment disorder concept: validity and sensitivity to change of the Adjustment Disorder - New Module questionnaire in a clinical intervention study. International journal of methods in psychiatric research. 26:1545
   Web of Science ®Google Scholar
• Baldwin DS, Anderson IM, Nutt DJ, Allgulander C, Bandelow B, den Boer JA, Christmas DM, Davies S, Fineberg N, Lidbetter N, et al. 2014. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 28:403–439.
   PubMed Web of Science ®Google Scholar
• Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Moller HJ. Care WTFoMDiP, Wfsbp Task Force on Anxiety Disorders OCD, Ptsd. 2012. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract. 16:77–84.
   PubMed Web of Science ®Google Scholar
• Bourin M, Bougerol T, Guitton B, Broutin E. 1997. A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placebo. Fundam Clin Pharmacol. 11:127–132.
   PubMed Web of Science ®Google Scholar
• Carta MG, Balestrieri M, Murru A, Hardoy MC. 2009. Adjustment disorder: epidemiology, diagnosis and treatment. Clin Pract Epidemiol Ment Health. 5:15.
   PubMedGoogle Scholar
• Casey P. 2014. Adjustment disorder: new developments. Curr Psychiatry Rep. 16:451.
   PubMed Web of Science ®Google Scholar
• De Leo D. 1989. Treatment of adjustment disorders: a comparative evaluation. Psychol Rep. 64:51–54.
   PubMed Web of Science ®Google Scholar
• De Wit S, Cremers L, Hirsch D, Zulian C, Clumeck N, Kormoss N. 1999. Efficacy and safety of trazodone versus clorazepate in the treatment of HIV-positive subjects with adjustment disorders: a pilot study. J Int Med Res. 27:223–232.
   PubMed Web of Science ®Google Scholar
• Ferrer L, Kirchner T. 2015. Suicidal tendency among adolescents with adjustment disorder. Crisis 36:202–210.
   PubMedGoogle Scholar
• Fielden JS. 2012. Review: management of adjustment disorder in the deployed setting. Mil Med. 177:1022–1027.
   PubMed Web of Science ®Google Scholar
• Galecki P, Zboralski K, Florkowski A. 2005. The efficacy and safety of trazodone in the treatment of adjustment disorders–naturalistic research. Pol Merkur Lekarski. 19:183–187.
   PubMedGoogle Scholar
• Hameed U, Schwartz TL, Malhotra K, West RL, Bertone F. 2005. Antidepressant treatment in the primary care office: outcomes for adjustment disorder versus major depression. Ann Clin Psychiatry. 17:77–81.
   PubMedGoogle Scholar
• Horowitz MJ. 1986. Stress-response syndromes: a review of posttraumatic and adjustment disorders. Hosp Community Psychiatry. 37:241–249.
   PubMedGoogle Scholar
• Laugharne J, van der Watt G, Janca A. 2009. It is too early for adjusting the adjustment disorder category. Curr Opin Psychiatry. 22:50–54.
   PubMed Web of Science ®Google Scholar
• Maercker A, Brewin CR, Bryant RA, Cloitre M, van Ommeren M, Jones LM, Humayan A, Kagee A, Llosa AE, Rousseau C, et al. 2013. Diagnosis and classification of disorders specifically associated with stress: proposals for ICD-11. World Psychiatry. 12:198–206.
   PubMed Web of Science ®Google Scholar
• Miyasaka LS, Atallah AN, Soares BG. 2006. Valerian for anxiety disorders. Cochrane Database Syst Rev. 18:CD004515.
   Google Scholar
• Miyasaka LS, Atallah AN, Soares BG. 2007. Passiflora for anxiety disorder. Cochrane Database Syst Rev. 24:CD004518.
   Google Scholar
• Nesse RM, Stein DJ. 2012. Towards a genuinely medical model for psychiatric nosology. BMC Med. 10:5.
   PubMed Web of Science ®Google Scholar
• Nguyen N, Fakra E, Pradel V, Jouve E, Alquier C, Le Guern ME, Micallef J, Blin O. 2006. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice. Hum Psychopharmacol. 21:139–149.
   PubMed Web of Science ®Google Scholar
• O’Keeffe N, Ranjith G. 2007. Depression, demoralisation or adjustment disorder? Understanding emotional distress in the severely medically ill. Clin Med (Lond). 7:478–481.
   PubMed Web of Science ®Google Scholar
• Razavi D, Delvaux N, Farvacques C, De Brier F, Van Heer C, Kaufman L, Derde MP, Beauduin M, Piccart M. 1993. Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. JCO. 11:1384–1390.
   PubMed Web of Science ®Google Scholar
• Razavi D, Kormoss N, Collard A, Farvacques C, Delvaux N. 1999. Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot study. J Int Med Res. 27:264–272.
   PubMed Web of Science ®Google Scholar
• Servant D, Graziani PL, Moyse D, Parquet PJ. 1998. Treatment of adjustment disorder with anxiety: efficacy and tolerance of etifoxine in a double-blind controlled study. L'Encephale 24:569–574.
   PubMed Web of Science ®Google Scholar
• Stahl SM. 2002. Don’t ask, don’t tell, but benzodiazepines are still the leading treatments for anxiety disorder. J Clin Psychiatry. 63:756–757.
   PubMed Web of Science ®Google Scholar
• Stein DJ. 2015. Etifoxine versus alprazolam for the treatment of adjustment disorder with anxiety: a randomized controlled trial. Adv Ther. 32:57–68.
   PubMed Web of Science ®Google Scholar
• Stein DJ, Nesse RM. 2011. Threat detection, precautionary responses, and anxiety disorders. Neurosci Biobehav Rev. 35:1075–1079.
   PubMed Web of Science ®Google Scholar
• Strain JJ, Friedman MJ. 2011. Considering adjustment disorders as stress response syndromes for DSM-5. Depress Anxiety. 28:818–823.
   PubMed Web of Science ®Google Scholar
• Strain JJ, Smith GC, Hammer JS, McKenzie DP, Blumenfield M, Muskin P, Newstadt G, Wallack J, Wilner A, Schleifer SS. 1998. Adjustment disorder: a multisite study of its utilization and interventions in the consultation-liaison psychiatry setting. Gen Hosp Psychiatry. 20:139–149.
   PubMed Web of Science ®Google Scholar
• Syunyakov TS, Neznamov GG. 2016. [Evaluation of the therapeutic efficacy and safety of the selective anxiolytic afobazole in generalized anxiety disorder and adjustment disorders: results of a multicenter randomized comparative study of diazepam]. Ter Arkh. 88:73–86.
   PubMed Web of Science ®Google Scholar
• Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, et al. 2009. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ. 180:E47–E57.
   PubMed Web of Science ®Google Scholar
• Volz HP, Kieser M. 1997 . Kava-kava extract WS 1490 versus placebo in anxiety disorders-a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry 30:1–5.
   PubMed Web of Science ®Google Scholar
• Woelk H, Arnoldt KH, Kieser M, Hoerr R. 2007. Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial. J Psychiatr Res. 41:472–480.
   PubMed Web of Science ®Google Scholar
• Zeitler A, Kamoun N, Goyon S, Wahis J, Charlet A, Poisbeau P, Darbon P. 2016. Favouring inhibitory synaptic drive mediated by GABA(A) receptors in the basolateral nucleus of the amygdala efficiently reduces pain symptoms in neuropathic mice. Eur J Neurosci. 43:1082–1088.
   PubMed Web of Science ®Google Scholar
• Zimmerman M, Martinez JH, Dalrymple K, Chelminski I, Young D. 2013. “Subthreshold” depression: is. J Clin Psychiatry. 74:470–476.
   PubMedGoogle Scholar